A model allowing the design of modified nucleosides as HIV-RT inhibitors

Author： Pepe G.   Meyer M.   Faury P.   Graciet J.   Chermann J.   Kraus J.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.31, Iss.10, 1996-01, pp. : 775-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 reverse transcriptase inhibitors: beyond classic nucleosides and non-nucleosides

By Scarth Brian J   Ehteshami Maryam   Beilhartz Greg L   Göötte Matthias  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 581-598

Future Medicine

Access to resources Recommend Favorite

HIV-1 RT Nonnucleoside Inhibitors and Their Interaction with RT for Antiviral Drug Development

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 391-413

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Development of Integrase Inhibitors as Anti-HIV Agents

By  

Current Medicinal Chemistry, Vol. 10, Iss. 18, 2003-09 ,pp. : 1779-1794

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to the Design of Effective HIV-1 Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 7, Iss. 4, 2000-04 ,pp. : 455-477

Bentham Science Publishers

Access to resources Recommend Favorite